Our Science

Publications and Presentations

Date
Title
April 2019
Efficacy of Ibrexafungerp (formerly SCY-078) Against Pneumocystis Pneumonia in a Murine Therapeutic Model. Stephen A. Barat, Katyna Borroto-Esoda, David A. Angulo, Alan Ashbaugh, Melanie Cushion
ECCMID 2019
April 2019
Oral Ibrexafungerp (SCY-078) in Refractory Fungal Diseases Oliver A. Cornely MD, FECMM, FIDSA, FAAM, FACP
Consultant, Infectious Diseases
Director, European Mycology Excellence Center
University Hospital of Cologne
ECCMID 2019
March 2019
Ibrexafungerp: Activity against Pneumocystis S. Barat
Superbugs and Superdrugs 2019
September 2018
June 2018
In vitro Activity of SCY-078 in Combination with Isavuconazole or Amphotericin B against Medically Important Moulds V. Petraitis, P. Kavaliauskas, R. Planciuniene, M.Viragailis, R.Petraitiene, S.Barat, K. Borroto-Esoada, D. Angulo, T. Walsh
ASM Microbe 2018
February 2018
October 2017
SCY-078 Demonstrates Significant Antifungal Activity in a Murine Model of Invasive Aspergillosis K. Borroto-Esoda, S. Barat, D. Angulo, C. Carruthers, K. Holden, P. Warn
IDWeek 2017